Photodynamictherapy (PDT) is a treatment that uses special drugs, sometimes called photosensitizing agents, along with light to kill cancer cells. The drugs only work after they have been activated or “turned on” by certain kinds of light. PDT may also be called photoradiation therapy, phototherapy, or photochemotherapy. Aswith any procedure, the recovery time for mole removal varies. You should feel back to normal within days to weeks, depending on whether or not you got stitches. When it comes to overall CosmeticSurgery in Long Beach, California. Whether you are in need of cosmetic surgery procedures such as varicose vein reduction, botox, fillers or just enhancement of you beauty, our center provides personalized care and always follows up to ensure your expectations are met. Let our doctor’s background and experience work for your look.. Estea Laser & Cosmetic Center Fast Money. The efficacy and safety of pro-yellow laser treatment for the management of vascular skin lesions was reported in study data published in the Journal of Cosmetic Dermatology. In a study of patients with myriad vascular skin conditions, treatment with 577-nm pro-yellow laser was associated with substantial improvement in lesion size and appearance. Treatment was well tolerated by all patients. Although pro-yellow laser is an established treatment method for diabetic retinopathy, only a limited number of studies have evaluated its efficacy and safety for the management of vascular skin lesions. To close this gap, investigators retrospectively assessed the outcomes of patients who received treatment with a pro-yellow laser at a dermatology clinic in Turkey. Patients with a clinical diagnosis of any vascular skin condition were eligible for inclusion; their demographic data and clinical history were extracted from medical records. All patients received treatment with the same laser apparatus at 4-week intervals. Treatment efficacy was assessed through clinical examination performed at baseline and 4 weeks after the last laser session. Improvement was rated by clinicians on an ordinal scale based on level of lesion improvement “excellent” 75% to 100% improved, “very good” 50% to 74%, “good” 25% to 49%, and “poor” less than25%. Adverse events were catalogued and reported. A total of 74 patients received pro-yellow laser treatment at the participating dermatology clinic. Their mean age was years and the majority were women. Patient skin phototypes ranged from Fitzpatrick type 2 to type 3 Various vascular skin conditions were represented in the cohort, including facial telangiectasia n=37, erythematotelangiectatic rosacea n=13, port-wine stain n=6, spider angioma n=6, venous lake n=6, cherry angioma n=4, and scrotal angiokeratoma n=2. The mean number of laser sessions varied by diagnostic group, and ranged from 1 to Very good to excellent improvement was observed in the majority of the study cohort. Among patients with facial telangiectasia, and experienced excellent or very good improvement, respectively. In patients treated for rosacea, experienced excellent improvement, experienced very good improvement, and experienced good improvement. In patients with venous lake, results were evenly divided between excellent 50% and very good 50% improvement. All patients with cherry angioma, spider angioma, and scrotal angiokeratoma experienced excellent improvement following laser treatment. The only reported adverse event was erythema in the treatment area, which resolved within 24 to 48 hours of laser application. Treatment efficacy was not significantly associated with patient age, sex, or skin phototype. Based on these results, pro-yellow laser is an effective, safe option for the management of vascular skin lesions. However, because the trial did not enroll patients with severe vascular problems, results cannot be extrapolated to more serious lesions. “[The] pro-yellow laser provides efficient results without side effects like edema, petechia and purpura,” investigators wrote. “The pro-yellow device is small, compact, user friendly and has [an] integrated cooling system [and] these features make it practical for daily use in dermatology clinics.” Reference Aksoy Sarac G, Onder M. Evaluation of the efficacy of pro-yellow laser in the management of vascular skin disorders. J Cosmet Dermatol. Published online April 19, 2021. doi . 2022 Jan;211316-319. doi Epub 2021 Dec 8. Affiliations PMID 34889036 DOI A new treatment option for poikiloderma of Civatte 577 nm pro-yellow laser Gulbahar Sarac et al. J Cosmet Dermatol. 2022 Jan. Abstract Background Although many laser systems have been used in the treatment for Poikiloderma of Civatte POC, there is no standard treatment guideline. Objectives We aimed to present our data on the efficacy and safety of single-session pro-yellow laser treatment for POC. Methods The study included 14 patients treated with pro-yellow laser QuadroStarPRO YELLOW Asclepion Laser Technologies, Germany between 2017 and 2019. Treatment had been applied in two passes during the same session; a general pass with 22 j/cm2 over the whole lesion, then, one more pass only on the telangiectatic lesions with 18 j/cm2 fluence. They were evaluated based on their pictures taken before and 4 weeks after the treatment and scored by a 4-item scoring in terms of the improvement 0no change, 11%-25% mild, 226%-50% moderate, 351%-75% well, and 476%-100% excellent improvement. Results The mean age of the patients 1 female, 13 males was ± years. Five patients had Fitzpatrick-2 and 9 patients had Fitzpatrick-3 skin types. Six patients had mild, 8 patients had moderate improvement, one of them has been illustrated in Figure 1. Sixty-minute mild erythema was the only adverse effect observed. Conclusions We think that pro-yellow laser is a good treatment option for POC treatment. Repeated sessions are required for the complete healing of the lesions, while one single session has proved to be deficient. We observed that it was a quite safe treatment option, especially for the neck region, which was inclined to scarring and atrophy development. Keywords 577 nm; poikiloderma of civatte; pro-yellow laser; vascular laser. © 2021 Wiley Periodicals LLC. Similar articles An evaluation of the efficacy of a single-session 577 nm pro-yellow laser treatment in patients with postacne erythema and scarring. Sarac G, Kapicioglu Y, Cenk H. Sarac G, et al. Dermatol Ther. 2021 Jan;341e14611. doi Epub 2020 Dec 10. Dermatol Ther. 2021. PMID 33258538 Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser a case series. Kapicioglu Y, Sarac G, Cenk H. Kapicioglu Y, et al. Lasers Med Sci. 2019 Feb;34193-98. doi Epub 2018 Aug 10. Lasers Med Sci. 2019. PMID 30097757 Treatment of poikiloderma of Civatte using intense pulsed light source 7 years of experience. Rusciani A, Motta A, Fino P, Menichini G. Rusciani A, et al. Dermatol Surg. 2008 Mar;343314-9; discussion 319. doi Epub 2007 Dec 19. Dermatol Surg. 2008. PMID 18177401 Clinical Trial. Delivery of light to the skin through ablated conduits. Tanghetti E, Mirkov M, Sierra RA. Tanghetti E, et al. Lasers Surg Med. 2017 Jan;49169-77. doi Epub 2016 May 19. Lasers Surg Med. 2017. PMID 27197620 Review. References REFERENCES Meijs MM, Blok FA, de Rie MA. Treatment of poikiloderma of Civatte with the pulsed dye laser a series of patients with severe depigmentation. J Eur Acad Dermatol Venereol. 2006;20101248-1251. Temiz SA, Ataseven A, Dursun R, Özer İ. Successful treatment of poikiloderma of Civatte with a 577-nm pro-yellow laser. J Cosmet Dermatol. 2020;19102769-2770. Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser a case series. Lasers Med Sci. 2019;34193-98. Sarac G, Kapicioglu Y. Efficacy of 577-nm pro-yellow laser in port wine stain treatment. Dermatol Ther. 2019;326e13078. Haywood RM, Monk BE. Treatment of poikiloderma of Civatte with the pulsed dye laser a series of seven cases. J Cutan Laser Ther. 1999;1145-48. MeSH terms LinkOut - more resources Full Text Sources Ovid Technologies, Inc. Wiley Medical MedlinePlus Health Information Sun damage, dark spots, and unwanted pigmentation are skin imperfections that many people go to great lengths to hide or remove. Featured on The Doctors television show, one patient finally achieved the results she longed for using the QuadroStarPRO YELLOW laser after years of failed treatments and expensive temporary solutions for concealing her melasma. During this special episode of The Doctors, we meet Trisha, a PR consultant and TV host based in Las Vegas. Due to the public nature of her work, she must always be camera-ready and able to put her best foot forward. We learn that Trisha has struggled with melasma, sun damage, and Lupus for more than 20 years, causing her skin to appear uneven with dark spots and redness. Feeling self-conscious of her skin's natural appearance, Trisha avoids public outings with her daily heavy makeup coverage sometimes spending more than $750 a month on cosmetics. Trisha has tried many laser treatments, including IPL, but has never achieved lasting results. During her consultation, Dr. Gregory Mueller, a board-certified plastic surgeon, recommends treatment with the QuadroStar PRO YELLOW laser. Almost immediately after her first treatment with the PRO YELLOW, Trisha is thrilled by her initial results, even noting some dark spots had already vanished. Thanks to the PRO YELLOW's unique yellow wavelength and other optimized features, it's become the ultimate solution for melasma, vascular lesions, dark spots, and more, similar to Trisha's unwanted pigmentation. With the help of the PRO YELLOW's innovative technology, Trisha is finally able to enjoy lasting results and feel confident in her skin without heavy foundation and makeup. The yellow 577 nm wavelength produced by the QuadroStarPRO YELLOW lies at the maximum hemoglobin absorption limit. This absorption is 40% higher than that of KTP lasers. Thus it is more selective, allowing for increased precision in targeting unwanted lesions. Maximum hemoglobin absorption levels, unparalleled exactness, and various unique treatment modes make the QuadroStarPRO YELLOW the gold standard for treating vascular lesions. Compared to the green KTP laser 532 nm, The QuadroStarPRO YELLOW requires less fluence to achieve the same results. Because the PRO YELLOW has a lower level of melanin absorption than KTP lasers, it can effectively treat darker skin types with less damage and significantly reduced unwanted side effects such as hypopigmentation. Learn More About the QuadroStarPRO YELLOW The is QuadroStarPRO YELLOW was designed by Germany-based aesthetics leader, Asclepion Laser Technologies, and it is distributed and sold in the United States exclusively by Astanza Laser. The QuadroStarPRO YELLOW is the newest technology dedicated to treating superficial vessels, pigmented lesions, and other popular aesthetic indications. Recently, Asclepion hosted an exclusive webinar with world-renowned research and dermatology professor, Professor Essamelden M. Mohamed. Here, both parties discuss why the QuadroStarPRO YELLOW's unique yellow wavelength, six treatment modes, and high-tech accessories make this device an essential laser for any dermatology and aesthetic practice. During this webinar, viewers will see a demonstration of the QuadroStarPRO YELLOW, before and after photos, case studies, and hear why Dr. Mohamed believes this device is the gold standard for vascular and non-vascular procedures. Click here to watch the exclusive webinar for free!

pro yellow laser before and after